
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/05/2025 | Q3 | $318.3M | -- | -- | $0.62 | -- |
05/30/2025 | Q2 | $280.7M | $277.7M | $0.34 | $0.30 | $0.04 |
03/20/2025 | Q1 | $275.9M | $262.9M | $0.53 | $0.44 | $0.09 |
11/21/2024 | Q4 | $316.2M | $306.9M | $0.70 | $0.67 | $0.03 |
09/05/2024 | Q3 | $336.3M | $332.7M | $0.82 | $0.83 | -$0.01 |
05/23/2024 | Q2 | $294.5M | $300.4M | $0.63 | $0.60 | $0.03 |
03/21/2024 | Q1 | $280.3M | $280.2M | $0.57 | $0.59 | -$0.02 |
11/16/2023 | Q4 | $321.3M | $319.9M | $0.80 | $0.97 | -$0.17 |
08/29/2023 | Q3 | $286.3M | $294.6M | $0.71 | $0.84 | -$0.13 |
05/24/2023 | Q2 | $288.2M | $281.2M | $0.60 | $0.75 | -$0.15 |
03/22/2023 | Q1 | -- | $290.8M | $0.79 | -- | -- |
11/16/2022 | Q4 | -- | $341.7M | $1.18 | -- | -- |
08/25/2022 | Q3 | -- | $312.3M | $1.04 | -- | -- |
05/18/2022 | Q2 | -- | $317.5M | $0.95 | -- | -- |
03/16/2022 | Q1 | -- | $313.4M | $0.72 | -- | -- |
11/17/2021 | Q4 | -- | $356.3M | $1.64 | -- | -- |
08/25/2021 | Q3 | -- | $332.2M | $1.54 | -- | -- |
05/19/2021 | Q2 | -- | $328.5M | $1.51 | -- | -- |
03/24/2021 | Q1 | -- | $253.9M | $0.26 | -- | -- |
11/18/2020 | Q4 | -- | $274.6M | $0.51 | -- | -- |
09/01/2020 | Q3 | -- | $300.8M | $0.35 | -- | -- |
05/20/2020 | Q2 | -- | $147.5M | -$0.58 | -- | -- |
03/25/2020 | Q1 | -- | $239.9M | $0.12 | -- | -- |
11/21/2019 | Q4 | -- | $274.6M | $0.47 | -- | -- |
08/28/2019 | Q3 | -- | $268.2M | $0.40 | -- | -- |
05/22/2019 | Q2 | -- | $253.8M | $0.46 | -- | -- |
03/26/2019 | Q1 | -- | $234.7M | $0.05 | -- | -- |
11/15/2018 | Q4 | -- | $269.2M | $0.38 | -- | -- |
08/28/2018 | Q3 | -- | $268.4M | $0.38 | -- | -- |
05/24/2018 | Q2 | -- | $257.4M | $0.42 | -- | -- |
03/27/2018 | Q1 | -- | $243.2M | -$0.12 | -- | -- |
11/16/2017 | Q4 | -- | $287.5M | $0.33 | -- | -- |
08/30/2017 | Q3 | -- | $235.1M | $0.12 | -- | -- |
05/25/2017 | Q2 | -- | $253.4M | $0.24 | -- | -- |
03/23/2017 | Q1 | -- | $234.2M | -$0.03 | -- | -- |
11/28/2016 | Q4 | -- | $274.5M | $0.27 | -- | -- |
08/31/2016 | Q3 | -- | $231.9M | $0.11 | -- | -- |
05/19/2016 | Q2 | -- | $260.5M | $0.28 | -- | -- |
03/17/2016 | Q1 | -- | $233.7M | $0.11 | -- | -- |
11/30/2015 | Q4 | -- | $269.7M | $0.24 | -- | -- |
09/01/2015 | Q3 | -- | $227.8M | $0.12 | -- | -- |
Shoe Carnival reported $277.7M worth of top line sales in its most recent quarter.
Shoe Carnival announced earnings per share of $0.34 which represents a beat of analyst forecast a $0.30 per share.
Shoe Carnival reported $95.8M that represents $3.49 per share over the last quarter.
Shoe Carnival's earnings are forecast to decrease from $2.68 per share to $2.63 per share next year representing a decrease of -30.35%.
Shoe Carnival's next earnings date is September 5, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.